Cell Culture Market Worth $57.9 billion | MarketsandMarkets - Seite 2

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Growth opportunities in emerging economies

Key Market Drivers

Increasing fundings for cell-based research

 

The consumables segment accounted for the largest share of the product segment in the cell culture market in 2023.

Based on products, the cell culture market is segmented into consumables and equipment. Consumables are further segmented into sera, media, reagents; vessels; and accessories. Equipment is further categorized as bioreactors, storage equipment, and other equipment. Consumables segment dominated the market in 2023 and is expected to grow at a higher rate during the forecast. The largest share of the segment is attributed to repetitive purchase of media & reagents, and growing R&D activities to develop and manufacture advanced therapies.

The pharmaceutical and biotechnology companies' segment is estimated to register the highest growth rate during the forecast period in the cell culture market.

Based on end user, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies' segment is estimated to register the highest growth rate during the forecast period. The rising demand for advanced therapies such as regenerative medicine due to increasing prevalence of chronic diseases is expected to boost the growth of pharmaceutical & biotechnology companies' segment in coming years.

The Asia Pacific region is the fastest-growing region of the cell culture market in 2023.

Based on the region, the cell culture market is segmented into major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific is anticipated to register fastest growth in the cell culture owing to the increasing focus on advancement of biopharmaceutical industry, high government investments & fundings for R&D, and growing demand for cell and gene therapy.